<DOC>
	<DOCNO>NCT01955148</DOCNO>
	<brief_summary>This study design determine quantitative analysis fetal Fibronectin ( fFN ) use advance prediction spontaneous preterm birth ( sPTB ) . This prospective observational multi-center study approximately 15 20 US site , approximately 1210 subject evaluate clinical utility Rapid fFN 10Q system preterm birth risk assessment . A single fFN specimen collect subject 16 week , 0 day 21 week , 6 day . The primary secondary maternal outcome measure determine base date delivery estimate date confinement ( EDC ) , evaluate standardized manner .</brief_summary>
	<brief_title>fFN Clinical Evaluation Asymptomatic Women High Risk Preterm Birth</brief_title>
	<detailed_description>Hologic develop quantitative test ass amount fetal fibronectin ( fFN ) present cervicovaginal secretion , evaluate clinical utility test assess spontaneous Pre-Term Bith risk high risk population . Identifying woman high risk give birth prematurely challenge . It believe high level fFn measure vaginal fluid suggest woman great risk deliver early . fFN test already approve use woman week 22 35 pregnancy . The goal study evaluate benefit collect fFN measurement vaginal fluid specimen take early pregnancy ( 16 week 22 week ) ass risk pre-term birth .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>1 . Pregnant woman 16 week , 0 day 21 week , 6 day ' gestation 2 . Maternal age ≥18 year age 3 . Subject sign dated Institutional Review Board ( IRB ) approve consent form participate study 4 . Subjects study must high risk preterm birth indicate least one following : A previous delivery live bear singleton 20 week , 0 day 36 week , 6 day due spontaneous preterm premature labor preterm rupture fetal membrane Short cervical length ( ≤25 mm ) determine transvaginal ultrasound Current twin pregnancy Cervical cerclage prior pregnancy Prior cone biopsy Prior LEEP / LLETZ 1 . Maternal age 18 2 . Suspected proven rupture fetal membrane time specimen collection 3 . Known significant congenital structural chromosomal fetal anomaly 4 . Women moderate gross bleeding evident speculum examination 5 . Women sexual intercourse within 24 hour prior specimen collection 6 . Cervical cerclage time specimen collection 7 . Current triplet ( ) pregnancy 8 . Placenta previa active bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>PTB</keyword>
	<keyword>sPTB</keyword>
	<keyword>cervical cerclage</keyword>
	<keyword>LEEP</keyword>
	<keyword>PROM</keyword>
	<keyword>short cervix</keyword>
</DOC>